Clinical Trial Update: Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SK-1404 for nocturia due to nocturnal polyuria in Japanese subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia
• Nocturnal Polyuria

Drugs mentioned

• SK-1404 (SK-1404)

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Nocturia Due to Nocturnal Polyuria | Phase 2 | Status: COMPLETED